HealthFDA warns of vision-loss risk linked to popular GLP-1 drugs such as Wegovy and Zepbound
The FDA says it has found evidence of a potential increase in the risk of a rare eye condition associated with GLP-1 drugs used for weight management and diabetes, including drugs such as Wegovy and Zepbound.
FDA warns of vision-loss risk linked to popular GLP-1 drugs such as Wegovy and Zepbound
Health